HIV screening
This article was originally published in The Gray Sheet
Executive Summary
In a Sept. 9 1memo, CMS proposes to extend national coverage to lab-based immunoassay and rapid antibody assay screening for HIV in certain high-risk individuals, per U.S. Preventive Service Task Force guidelines. The agency opened its analysis for HIV screening on March 13, marking the first time CMS has initiated a national coverage determination for a screening tool since Congress granted it authority to add coverage for certain preventative services without the need for case-by-case congressional approval (2"The Gray Sheet" March 30, 2009). A final decision is expected by Dec. 8
You may also be interested in...
CMS Weighs Coverage Of HIV Tests Under Preventive Services Authority
Routine screening for the human immunodeficiency virus (HIV) could get a boost if a CMS national coverage analysis initiated March 13 leads to Medicare reimbursement
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.